Sofinnova Investments, Inc.
- SEC CIK
- 0001631134
- Latest filing
- Aug 14, 2026
DYN holding history
Dyne Therapeutics, Inc. in every 13F filed by Sofinnova Investments, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DYN overviewAll 13F holders of DYNFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,658,384
- Value
- $36.8M
- % of portfolio
- 2.0%
- Quarters held
- 13
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,658,384 | $36.8M | 2.0% | +24,487+1.5% | Added | Holders |
| Q1 2026 | 1,633,897 | $29.6M | 1.5% | −620,264−27.5% | Reduced | Holders |
| Q4 2025 | 2,254,161 | $44.1M | 1.9% | +1,268,333+128.7% | Added | Holders |
| Q3 2025 | 985,828 | $12.5M | 0.8% | +370,963+60.3% | Added | Holders |
| Q2 2025 | 614,865 | $5.85M | 0.4% | −102,031−14.2% | Reduced | Holders |
| Q1 2025 | 716,896 | $7.50M | 0.6% | −354,602−33.1% | Reduced | Holders |
| Q4 2024 | 1,071,498 | $25.2M | 1.9% | +299,428+38.8% | Added | Holders |
| Q3 2024 | 772,070 | $27.7M | 2.3% | −853,633−52.5% | Reduced | Holders |
| Q2 2024 | 1,625,703 | $57.4M | 3.6% | −310,947−16.1% | Reduced | Holders |
| Q1 2024 | 1,936,650 | $55.0M | 3.2% | +923,145+91.1% | Added | Holders |
| Q4 2023 | 1,013,505 | $13.5M | 0.8% | +328,372+47.9% | Added | Holders |
| Q3 2023 | 685,133 | $6.14M | 0.4% | +244,085+55.3% | Added | Holders |
| Q2 2023 | 441,048 | $4.96M | 0.3% | +441,048 | New | Holders |